Nothing Special   »   [go: up one dir, main page]

DE3273138D1 - Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms - Google Patents

Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms

Info

Publication number
DE3273138D1
DE3273138D1 DE8282104734T DE3273138T DE3273138D1 DE 3273138 D1 DE3273138 D1 DE 3273138D1 DE 8282104734 T DE8282104734 T DE 8282104734T DE 3273138 T DE3273138 T DE 3273138T DE 3273138 D1 DE3273138 D1 DE 3273138D1
Authority
DE
Germany
Prior art keywords
eustatic
nonspecifically
generalized
amplifying
repair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282104734T
Other languages
English (en)
Inventor
John A Osmundsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUPAN CORP
Original Assignee
EUPAN CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUPAN CORP filed Critical EUPAN CORP
Application granted granted Critical
Publication of DE3273138D1 publication Critical patent/DE3273138D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8282104734T 1981-06-02 1982-05-28 Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms Expired DE3273138D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26971781A 1981-06-02 1981-06-02

Publications (1)

Publication Number Publication Date
DE3273138D1 true DE3273138D1 (en) 1986-10-16

Family

ID=23028395

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282104734T Expired DE3273138D1 (en) 1981-06-02 1982-05-28 Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms

Country Status (3)

Country Link
EP (1) EP0066283B1 (de)
CA (1) CA1181693A (de)
DE (1) DE3273138D1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IT1228203B (it) * 1989-01-10 1991-06-05 Promo Int Srl Prodotto per la protezione, la nutrizione ed, in generale, la cura dei capelli, del cuoio capelluto, delle ciglia e delle unghie.
WO1990014095A1 (en) * 1989-05-26 1990-11-29 Maddren Lawrence T Topical treatment of herpesvirus hominis
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
EP0755256A4 (de) * 1994-03-28 1997-09-03 Skin Biology Inc Stärke-metall-komplexe für haut und haar
US6017901A (en) * 1995-05-10 2000-01-25 Fidia Advanced Bioplymers S.R.L. Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
FR2781485B1 (fr) * 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
WO2001013865A1 (en) 1999-08-20 2001-03-01 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1176917A (fr) * 1954-08-18 1959-04-17 American Home Prod Acide hyaluronique partiellement dépolymérisé comme agent de diffusion
US4058621A (en) * 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
EP0012115A1 (de) * 1978-12-04 1980-06-11 Ciba-Geigy Ag Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen

Also Published As

Publication number Publication date
EP0066283A1 (de) 1982-12-08
EP0066283B1 (de) 1986-09-10
CA1181693A (en) 1985-01-29

Similar Documents

Publication Publication Date Title
DE3273138D1 (en) Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms
ES516520A0 (es) "perfeccionamientos en las valvulas mezcladoras".
NO166525C (no) Metallplatebeholder og fremgangsmaate for fremstilling av samme.
EP0247167A4 (de) Hydroxy- und aminothiazolyl-benzodiazinonverbindungen, kardiotonische mittel, die diese enthalten und verwendungen.
DE3276875D1 (en) Improvements in or relating to relief valves for sanitation systems or the like
GB2110342B (en) Improvements in sliding gate valves
DK253782A (da) 5,5!-azobissalicylsyre i dianionisk form i kombination med en anionbytterharpiks og fremgangsmaade til dens fremstilling
DK30185A (da) Ventil med stroemkraftkompensator
AU4765390A (en) 5(substituted phenyl) -2-oxazolidinones and use in pharmaceuticals.
EP0247177A4 (de) Benzodiazinone-p und h-p-verbindungen, kardiotonische mittel, die diese enthalten und deren verwendungen.
IT8520896A0 (it) Perfezionamento nelle valvole di intercettazione.
DE3265800D1 (en) Non-linear amplifiers utilizing positive feedback
DE3260714D1 (en) N-substituted 2-methylnaphthyl amides, their preparation and their use as fungicides
AU557210B2 (en) Controlling the rolling efficiency in hot rolling
Sunahara Social exchange theory and the matching law
AU547031B2 (en) Heat yellow 13 in water
BG34423A1 (en) Scheme for regulating the position in positioning
AU556523B2 (en) Controlling the rolling efficiency in hot rolling
DE3270310D1 (en) Adjustable double choke valve
Lister The demand for provincial and local government bonds.
Dinsmore An historical analysis, documentary summary, and teaching proposal for" referential abstraction" in Canadian painting, 1940-1960
Barrett Numerical integration routines for the Gest simulation environment.
FI852405L (fi) Substituerade 3,4-diamino-1,2,5 -tiadiazoler med antagoniserande inverkan pao histaminets h2-receptorer.
Mills Theory to practice: understanding teaching through dialogue journals
Raworth Personal mobility rights in the EEC

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee